" class="no-js "lang="en-US"> Dr. Colin Hayward - Medtech Alert
Saturday, December 02, 2023
Dr. Colin Hayward | PTF

Dr. Colin Hayward

About Dr. Colin Hayward

Chief Medical Officer Biotech / Oncology / CRO

Related Story

Telix Pharmaceuticals ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU Along with Theranostic Pipeline Advances

December 22 2022

Telix Pharmaceuticals has announced that the completed pivotal Phase III ZIRCON study of TLX250-CDx in […]

First Patient Dosed in Phase II 'IPAX-Linz' Study of TLX101 for Glioblastoma Therapy

November 22 2022

Telix Pharmaceuticals has announced that a first patient has been dosed in a Phase II […]